Metal-cancellous L�beck total hip arthroplasty in hemodialysis patients

Abstract

We report the results of total hip arthroplasty (THA) in patients on hemodialysis (HD). The metal-cancellous cementless Lubeck (MCCL) prosthesis was used in a series of consecutive 17 patients between April 1996 and March 2000. The patients were evaluated clinically and radiographically, and data were recorded during prospective follow-up. We reviewed the 17 patients after follow-up for more than two years (mean, 3.7 years). At the latest review the mean Merle d`Aubigne and Postel total hip score had improved to 15.9 from a preoperative value of 7.8. Radiologically, there was no evidence of loosening. The revision rate was 6% (one hip) for the acetabular component and 6% (one hip) for the femoral component, which both occurred in the same patient due to deep infection. The complication rate was low, with no cases of intraoperative fracture or symptomatic deep venous thrombosis, but there was a 6% (one hip) rate of deep infection and a 6% (one hip) rate of dislocation. These findings demonstrate that good short-term results can be obtained using the MCCL prosthesis for HD patients. However, further follow-up is needed to determine the long-term outcome of this prosthesis.